| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197417 Having a reduced level of residual solvent(s); controlled-release microparticles having improved shelf-life |
| 10/07/2004 | US20040197416 contains dehydroepiandrosterone (DHEA) or its derivatives, aqueous medium, a polymer shell and a lipid core containing an oily solvent |
| 10/07/2004 | US20040197414 Controllably dissolvable silica-xerogels prepared via sol-gel process; delivery device including the silica-xerogel into which structure a biologically active agent is incorporated; drugs; Medical devices for orthopedic and surgical purposes |
| 10/07/2004 | US20040197413 Microparticle formation system; forming a plurality of droplets of the solution using a spray head in fluid communication with the solution source; low polydispersity, controlled integrity (e.g. shape and morphology) and stability (e.g., against aggregation) |
| 10/07/2004 | US20040197412 combining active ingredients with a supercritical carbon dioxide , and separating the active ingredients (antibiotics) from the supercritical fluid to yield a dry powder precipitate |
| 10/07/2004 | US20040197411 Acceptably non-hygroscopic formulation intermediate comprising a hygroscopic drug |
| 10/07/2004 | US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen |
| 10/07/2004 | US20040197408 Amino acids in micelle preparation |
| 10/07/2004 | US20040197407 sustained release; provide therapeutically effective average steady-state plasma cyclobenzaprine, amitriptyline, imipramine or desipramine concentration when administered once per day; uniformity in the release rate; by modifying the geometry of core layer interfaces |
| 10/07/2004 | US20040197406 Stool softener and enteric coated bisacodyl; tablets, capsule; laxative; administering the drug |
| 10/07/2004 | US20040197405 Multiparticulate modified release composition |
| 10/07/2004 | US20040197404 Extended release oral dosage form |
| 10/07/2004 | US20040197403 dry admixing paroxetine and dry excipients (sodium starch glycollate, dicalcium phosphate and magnesium stearate), compressing it into a slug material or roller it into a strand material, and milling the prepared material into a free flowing mixture; compressing the mixture into tablets; antidepressant |
| 10/07/2004 | US20040197402 Oxcarbazepine dosage forms |
| 10/07/2004 | US20040197400 Immediate release medicinal compositions for oral use |
| 10/07/2004 | US20040197398 Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor |
| 10/07/2004 | US20040197397 Drug delivery system for treatment of urinary incontinence |
| 10/07/2004 | US20040197394 Stable oral pharmaceutical dosage forms |
| 10/07/2004 | US20040197393 sandwich liposome comprises one or more biologically active agents internalized between two bilomellar liposomes; (1,2-bis(oleoyloxy)-3-(trimethylammonio)-propane) and cholesterol and a nucleic acid |
| 10/07/2004 | US20040197392 comprising 1-acyl-2-acyl-glycero-3-phosphoethanolamine and 1-acyl-2-acylsuccinylglycerol or 1-acyl-3-acylsuccinylglycerol; identification of a tumour, inflammation or cardiac infarct tissue in a human or non-human animal; Magnetic Resonance imaging |
| 10/07/2004 | US20040197391 Stable topical drug delivery compositions |
| 10/07/2004 | US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell |
| 10/07/2004 | US20040197386 Disposable paper-based hospital and operating theater products |
| 10/07/2004 | US20040197381 Enteral nutrition product and method for preparing the same |
| 10/07/2004 | US20040197377 Serotonin in liquid phase ; prepackaged drug delivery; antidepressants; obesity therapy; anxiolytic agents; headaches; psychological disorders; sleep disorders |
| 10/07/2004 | US20040197374 Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 10/07/2004 | US20040197369 Mixing active drug with macromer; polymerization |
| 10/07/2004 | US20040197368 Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents |
| 10/07/2004 | US20040197360 Hybrid composite dispersion; polycarbonateether block copolymer in aqueous solution |
| 10/07/2004 | US20040197352 Microencapsulaed or enteric coated; therapy for kidney disease; health of gastrointestinal system; probiotic bacteria which reduces creatine or organonitrogen compound |
| 10/07/2004 | US20040197340 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197331 Induction of cytotoxic T-lymphocyte responses |
| 10/07/2004 | US20040197323 Bioavailability; amidated in situ; adjustment of pH; protective barrier for stomach |
| 10/07/2004 | US20040197302 Positioning in mammalian body ; solidification when exposured to trigger |
| 10/07/2004 | US20040197280 Delivery of medicaments to the nail |
| 10/07/2004 | US20040197275 Crystallization from supersaturated solution by applying ultrasonic frequency |
| 10/07/2004 | US20040197273 Suspension aerosol formulations |
| 10/07/2004 | US20040197271 Therapy for respiratory system disorders; mixture of adrenergic blocking agent, corticosteroid with propellant; side effect reduction |
| 10/07/2004 | US20040197262 Micronized barium sulfate |
| 10/07/2004 | US20040195710 Generating biocompatible microspheres; obtain macromolecule solution, mix biocompatible particles, form geometric shapes, expose shape to radiation, recover microspheres |
| 10/07/2004 | US20040195206 Modification method of surface layer of molded resin article, and modification apparatus of surface layer of molded resin article |
| 10/07/2004 | US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof |
| 10/07/2004 | US20040194338 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 10/07/2004 | DE4035253B4 Injektionslösungen und Verfahren zu deren Herstellung Injection solutions and processes for their preparation |
| 10/07/2004 | DE10313196A1 Use of an emulsion comprising silicone, emulsifier, salt solution and dimethyl sulfoxide for treating or preventing diseases, e.g. resulting from the accumulation of harmful metabolites |
| 10/07/2004 | DE10064870B4 Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen Sulfur-containing amphiphiles for the transfer of biologically active molecules into cells |
| 10/07/2004 | DE10005936B4 Creme zur äußeren Anwendung auf der Nasenhaut Cream for topical application to the skin of the nose |
| 10/07/2004 | CA2520660A1 Solid oral dosage form containing seamless microcapsules |
| 10/07/2004 | CA2519962A1 Novel galenical system for active transport, method for preparation and use |
| 10/07/2004 | CA2519921A1 Asthma preparation |
| 10/07/2004 | CA2519707A1 Prostaglandin compositions for the treatment of erectile dysfunction |
| 10/07/2004 | CA2519705A1 Antifungal nail coat and method of use |
| 10/07/2004 | CA2519691A1 Angiogenesis promotion by prostaglandin compositions and methods |
| 10/07/2004 | CA2519536A1 Methods for the comminution and stabilization of small particles in suspension |
| 10/07/2004 | CA2519155A1 Formulations comprising an active ingredient and cocoa powder and use thereof |
| 10/07/2004 | CA2519119A1 Formulations comprising tolterodine and cocoa powder and use thereof |
| 10/07/2004 | CA2519038A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent |
| 10/07/2004 | CA2518223A1 Intravenous nanoparticles for targeting drug delivery and sustained drug release |
| 10/07/2004 | CA2517828A1 Compositions and methods for treatment of premature ejaculation |
| 10/06/2004 | WO2004047813A1 Solid mucoadhesive composition |
| 10/06/2004 | EP1464673A2 Polyanhydrides with biologically active degradation products |
| 10/06/2004 | EP1464341A1 Ubiquinone-containing water-soluble formulation for ophthalmic use |
| 10/06/2004 | EP1464338A1 Particle with a membrane |
| 10/06/2004 | EP1464331A1 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound |
| 10/06/2004 | EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation |
| 10/06/2004 | EP1463801A2 Transdifferentiation of pancreatic acinar cells |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1463583A1 Method for producing pharmaceutical preparations |
| 10/06/2004 | EP1463553A1 Medicament dispenser |
| 10/06/2004 | EP1463539A1 Controlled release therapeutic wound dressings |
| 10/06/2004 | EP1463515A2 Isoflavone composition for oral delivery |
| 10/06/2004 | EP1463513A1 Stabilized brivudine topical formulations |
| 10/06/2004 | EP1463497A2 Treating muscle wasting with selective androgen receptor modulators |
| 10/06/2004 | EP1463492A1 Adhesive and binding agent for dermal or transdermal treatment systems |
| 10/06/2004 | EP1463491A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 10/06/2004 | EP1463490A1 Glucan based film delivery systems |
| 10/06/2004 | EP1463489A1 Composite dosage forms |
| 10/06/2004 | EP1463488A1 Pharmaceutical composition comprising skimmed milk powder |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1463486A2 Anaesthetic compositions and method for their administration |
| 10/06/2004 | EP1463483A1 New composition |
| 10/06/2004 | EP1463440A2 Prevention of flap necrosis in plastic surgery |
| 10/06/2004 | EP1463438A2 Endomural therapy |
| 10/06/2004 | EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1414317A4 Edible articles that include edible optical elements and methods for producing same |
| 10/06/2004 | EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 10/06/2004 | EP1349561B1 Essential oils for the local treatment of herpes labialis |
| 10/06/2004 | EP1317255B1 Delivery capsules |
| 10/06/2004 | EP1303276B1 A bioavailable dosage form of loratadine |
| 10/06/2004 | EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent |
| 10/06/2004 | EP1244426A4 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer |
| 10/06/2004 | EP1239834B1 Mixed structures resulting from the incorporation of a biological macromolecule, especially dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 10/06/2004 | EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use |
| 10/06/2004 | EP1185256B1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 10/06/2004 | EP1165716B1 Adhesives |
| 10/06/2004 | EP1161225B1 Metered dose inhalers with isobutane as propellant |